Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments

Sarepta Therapeutics (SRPT) Posts Smaller Q1 Loss

May 4, 2022 5:22 PM EDT

Sarepta Therapeutics (NASDAQ: SRPT) reported Q1 EPS of ($0.56), $0.71 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $188.8 million versus the consensus estimate of $206.44 million.

For earnings history and earnings-related data on Sarepta Therapeutics (SRPT) click here.

... More